|
2024 Other Outputs Peptide Inhibitors of Interleukin-23 ReceptorBarros, Stephanie A., Neelamkavil, Santhosh Francis, Sun, Chengzao, Guo, Boying, Hendrick, Charles, Marcoux, David, Somani, Sandeep, Thieu, Tho, Zhang, Jing, Branca, Danila, Costante, Roberto, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2024). Peptide Inhibitors of Interleukin-23 Receptor. US20240279281. |
|
2024 Other Outputs Peptide inhibitors of interleukin-23 receptor Barros Stephanie A., Neelamkavil, Santhosh Francis, Sun, Chengzao, Hendrick, Charles, Patch, Raymond J., Somani, Sandeep, Zhang, Jing, Bianchi, Elisabetta, Branca, Danila, Costante, Roberto, Costantini, Willy, Ingenito, Raffaele, Lollobrigida, Martina, Rinaldi, Antonia, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2024). Peptide inhibitors of interleukin-23 receptor . WO2024155547A2. |
|
2024 Other Outputs Peptide inhibitors of interleukin-23 receptorBarros Stephanie A., Neelamkavil, Santhosh Francis, Sun, Chengzao, Guo, Boying, Hendrick, Charles, Marcoux, David, Somani, Sandeep, Thieu, Tho, Zhang, Jing, Branca, Danila, Costante, Roberto, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2024). Peptide inhibitors of interleukin-23 receptor. WO2024155546A1. |
|
2023 Conference Publication Iron restricted erythropoiesis under hepcidin mimetic treatment (PN23114) improved disease parameters in a mouse model for sickle cell diseaseTaranath, Roopa, Zhao, Li, Bourne, Gregory, Bhatt, Ramesh R., Plevy, Scott, Liu, David Y. and Bhandari, Ashok (2023). Iron restricted erythropoiesis under hepcidin mimetic treatment (PN23114) improved disease parameters in a mouse model for sickle cell disease. 65th Annual Meeting of the American Society of Hematology (ASH), San Diego, CA, United States, 9-12 December 2023. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2023-182472 |
|
2023 Other Outputs Hepcidin mimetics for treatment of sickle cell diseaseLiu, David Y., Bourne, Gregory Thomas, Taranath, Roopa and Zhao, Li (2023). Hepcidin mimetics for treatment of sickle cell disease. WO2023240077A1. |
|
2023 Other Outputs Conjugated hepcidin mimeticsBourne, Gregory Thomas, Bhandari, Ashok, Zhang, Jie, Smythe, Mark Leslie and Taranath, Roopa (2023). Conjugated hepcidin mimetics. WO2023150630A2. |
|
2022 Other Outputs Conjugated hepcidin mimeticsBhandari, Ashok, Zhang, Jie, Bourne, Gregory Thomas, Smythe, Mark Leslie, Tran, Tran Trung and Taranath, Roopa (2022). Conjugated hepcidin mimetics. WO2022212696A1. |
|
2022 Other Outputs Conjugated hepcidin mimeticsBourne, Gregory Thomas, Bhandari, Ashok, Zhang, Jie and Smythe, Mark Leslie (2022). Conjugated hepcidin mimetics. WO2023150618A2. |
|
2021 Other Outputs Conjugated hepcidin mimeticsBourne, Gregory Thomas, Bhandari, Ashok, Zhang, Jie, Frederick, Brian Troy and Smythe, Mark Leslie (2021). Conjugated hepcidin mimetics. WO2022026629A1. |
|
2021 Other Outputs Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesBhandari, Ashok, Frederick, Brian Troy, Tran, Tran Trung and Bourne, Gregory Thomas (2021). Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. WO2021146458. |
|
2021 Other Outputs Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesSun, Chengzao, Frederick, Brian Troy, Somani, Sandeep, Bourne, Gregory Thomas, Patch, Raymond, Bhandari, Ashok, Ingenito, Raffaele, Costante, Roberto, Branca, Danila and Bianchi, Elisabetta (2021). Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. WO2021146441A1. |
|
2020 Conference Publication Hepcidin peptidomimetics - oral efficacy in pre-clinical disease model of iron overloadTaranath, Roopa, Bourne, Gregory, Zhang, Jie, Frederick, Brian, Tran, Tran T., Bhandari, Ashok, Vengalam, Jayanthi, McMahon, Jaimee, Huie, Keith, Ledet, Grace A., Zhao, Li, Tovera, James, Lee, Larry, Yang, Bo, Dion, Celino, Yuan, Lucy, Zemede, Genet, Nguyen, Michelle, Masjedizadeh, Mohammad, Cheng, Xiaoli, Mattheakis, Larry, Liu, David and Smythe, Mark L. (2020). Hepcidin peptidomimetics - oral efficacy in pre-clinical disease model of iron overload. 62nd Annual Meeting of the American Society of Hematology (ASH), Virtual, 5-8 December 2020. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2020-141720 |
|
2020 Other Outputs Conjugated hepcidin mimeticsLiu, David Y., Bourne, Gregory Thomas, Taranath, Roopa, Gupta, Suneel Kumar and Modi, Nishit Bachulal (2020). Conjugated hepcidin mimetics. WO2021046246A1. |
|
2020 Other Outputs Conjugated hepcidin mimeticsLiu, David Y., Bourne, Gregory Thomas, Taranath, Roopa, Gupta, Suneel Kumar and Modi, Nishit Bachulal (2020). Conjugated hepcidin mimetics. WO2021046246. |
|
2019 Other Outputs Conjugated hepcidin mimeticsBourne, Gregory Thomas, Bhandari, Ashok, Frederick, Brian Troy, Zhang, Jie, Stephenson, Adam, Smythe, Mark Leslie, Taranath, Roopa and Liu, David (2019). Conjugated hepcidin mimetics. WO2019157268. |
|
2018 Other Outputs Opioid agonist peptides and uses thereofAnandan, Sampath Kumar, Zhang, Jie, Bhandari, Ashok, Bourne, Gregory Thomas and Frederick, Brian Troy (2018). Opioid agonist peptides and uses thereof. WO2019051494A1. |
|
2018 Conference Publication Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-DMattheakis, Larry, Anandan, Sampath-Kumar, Zhao, Li, Zerangue, Noa, Zhang, Jenny, Bourne, Greg T., Shah, Shairaz, Foulke, Matthew, Vinh Tran,, Tovera, James, Bai, Lu, Taranath, Roopa, Stephenson, Adam, Annamalai, Thamil, Bhandari, Ashok and Liu, David Y. (2018). Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-D. Annual Meeting of the American Society for Gastrointestinal Endoscopy / Digestive Disease Week, Washington, DC, United States, 2-5 June 2018. Philadelphia, PA, United States: Elsevier. |
|
2018 Other Outputs Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesBhandari, Ashok and Bourne, Gregory (2018). Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases. WO2018136646A1. |
|
2017 Conference Publication Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron OverloadBourne, Gregory, Zhao, Li, Bhandari, Ashok, Frederick, Brian, McMahon, Jaimee, Tran, Vinh, Zhang, Jenny, Stephenson, Adam, Tovera, James, Bai, Lu, Annamalai, Thamil, Patel, Dinesh, Smythe, Mark and Liu, David (2017). Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron Overload. Seventh Congress of the International BioIron Society (IBIS)Biennial World Meeting (BioIron 2017), Los Angeles, CA, United States, 7 - 11 May 2017. Hoboken, NJ United States: Wiley. |
|
2016 Other Outputs Analogues of hepcidin mimetics with improved in vivo half livesBourne, Gregory Thomas, Smythe, Mark Leslie, Frederick, Brian Troy and Bhandari, Ashok (2016). Analogues of hepcidin mimetics with improved in vivo half lives. WO2017117411A1. |
